Difficulty: Medium
Average Score: 76%
Practice
The primary reason for the use of drug combinations in the treatment of tuberculosis is to
Correct answer
D
Rationale
In the treatment of tuberculosis, the primary reason for using drug combinations is to delay or prevent the emergence of resistance (Option D). This is because tuberculosis is caused by Mycobacterium tuberculosis, a bacterium known for its ability to develop resistance to single drugs quickly. By using a combination of drugs with different mechanisms of action, it becomes harder for the bacteria to mutate and become resistant to all drugs simultaneously, thus preserving treatment efficacy.
Option A (Ensuring patient compliance) is important in tuberculosis treatment, but the primary reason for combination therapy is not just patient compliance. While compliance is crucial, it is not the primary reason for using drug combinations.
Option B (Reducing adverse effects) is a consideration in treatment, but the main purpose of drug combinations in tuberculosis is not solely to reduce adverse effects. It is primarily to prevent resistance.
Option C (Enhancing activity against metabolically inactive mycobacteria) is a valid consideration, but the primary reason for combination therapy in tuberculosis is to combat resistance rather than targeting metabolically inactive bacteria.
Educationally, understanding the rationale behind using drug combinations in tuberculosis treatment is essential for nurses, pharmacists, and other healthcare professionals to provide effective care, prevent resistance, and ensure successful treatment outcomes in patients with tuberculosis. This knowledge helps in making informed decisions regarding treatment strategies and reinforces the importance of adherence to prescribed medication regimens to combat this infectious disease effectively.
Option A (Ensuring patient compliance) is important in tuberculosis treatment, but the primary reason for combination therapy is not just patient compliance. While compliance is crucial, it is not the primary reason for using drug combinations.
Option B (Reducing adverse effects) is a consideration in treatment, but the main purpose of drug combinations in tuberculosis is not solely to reduce adverse effects. It is primarily to prevent resistance.
Option C (Enhancing activity against metabolically inactive mycobacteria) is a valid consideration, but the primary reason for combination therapy in tuberculosis is to combat resistance rather than targeting metabolically inactive bacteria.
Educationally, understanding the rationale behind using drug combinations in tuberculosis treatment is essential for nurses, pharmacists, and other healthcare professionals to provide effective care, prevent resistance, and ensure successful treatment outcomes in patients with tuberculosis. This knowledge helps in making informed decisions regarding treatment strategies and reinforces the importance of adherence to prescribed medication regimens to combat this infectious disease effectively.